1. Home
  2. Advisory Committees
  3. Advisory Committee Calendar
  4. UPDATED MEETING TIME AND PUBLIC PARTICIPATION INFORMATION: December 10, 2025: General Hospital and Personal Use Devices Panel Meeting Announcement - 12/10/2025
  1. Advisory Committee Calendar

Advisory Committee Meeting | Virtual

Event Title
UPDATED MEETING TIME AND PUBLIC PARTICIPATION INFORMATION: December 10, 2025: General Hospital and Personal Use Devices Panel Meeting Announcement
December 10, 2025

Date:
December 10, 2025
Time:
9:00 a.m. - 3:30 p.m. ET

What is an advisory committee?

Advisory committees provide independent expert advice to the FDA on broad scientific topics or on certain products to help the agency make sound decisions based on the available science. Advisory committees make non-binding recommendations to the FDA, which generally follows the recommendations but is not legally bound to do so. Please see, "Advisory Committees Give FDA Critical Advice and the Public a Voice," for more information.

Webcast Information:

YouTube:

https://youtu.be/kBXjDmJNye8

CenterDateTimeLocation
CDRHDecember 10, 20259:00 a.m. - 3:30 p.m.Virtual

SUMMARY:

The Food and Drug Administration (FDA) announces a forthcoming virtual meeting of the General Hospital and Personal Use Devices Panel of the Medical Devices Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to the FDA.

On December 10, 2025, the Advisory Committee will meet virtually to deliberate and make recommendations on issues related to an emerging technology in the context of medical devices and germicidal ultraviolet (UV) light as a mode of disinfection. The FDA is seeking to obtain feedback to improve the total product life cycle (TPLC) evaluation of UV disinfection devices. In addition, the Committee will meet to discuss and provide advice to the FDA on devices used in pandemic preparedness and response to satisfy, in part, a requirement under the Food and Drug Omnibus Reform Act of 2022 (FDORA).

DATES:

The meeting will be held virtually on December 10, 2025, from 9 a.m. to 3:30 p.m. ET. 

ADDRESSES:

Answers to commonly asked questions about FDA advisory committee meetings may be accessed at: https://www.fda.gov/​AdvisoryCommittees/​AboutAdvisoryCommittees/​ucm408555.htm.

PUBLIC COMMENT:

The FDA is establishing a docket for public comment on this meeting. The docket number is FDA-2025-N-0008. The docket will close on January 9, 2026. Please note that late, untimely filed comments will not be considered. The https://www.regulations.gov electronic filing system will accept comments until 11:59 p.m. Eastern Time at the end of January 9, 2026. Comments received by mail/hand delivery/courier (for written/paper submissions) will be considered timely if they are received on or before that date.

Comments received on or before December 1, 2025, will be provided to the Committee. Comments received after that date will be taken into consideration by the FDA. In the event that the meeting is cancelled, the FDA will continue to evaluate any relevant applications or information, and consider any comments submitted to the docket, as appropriate.

A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the agency’s website or call the committee’s Designated Federal Officer (see Contact Information) to learn about possible modifications before coming to the meeting.

Persons attending FDA’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with disabilities. If you require accommodations due to a disability, please contact the committee’s Designated Federal Officer (see Contact Information) at least 7 days in advance of the meeting.

Answers to commonly asked questions including information regarding special accommodations due to a disability may be accessed at: Common Questions and Answers about FDA Advisory Committee Meetings.

FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at Public Conduct During FDA Advisory Committee Meetings for procedures on public conduct during advisory committee meetings.

Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app.2).

Back to Top